HighMark Wealth Management LLC Has $5.29 Million Holdings in Paragon 28, Inc. (NYSE:FNA)

HighMark Wealth Management LLC lowered its position in Paragon 28, Inc. (NYSE:FNA) by 1.2% during the 4th quarter, Holdings Channel.com reports. The firm owned 512,144 shares of the company’s stock after selling 6,001 shares during the quarter. Paragon 28 accounts for about 3.0% of HighMark Wealth Management LLC’s investment portfolio, making the stock its 6th biggest position. HighMark Wealth Management LLC’s holdings in Paragon 28 were worth $5,290,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Venturi Wealth Management LLC bought a new stake in Paragon 28 in the fourth quarter worth about $36,000. Intech Investment Management LLC acquired a new stake in Paragon 28 during the 3rd quarter worth about $70,000. Ballentine Partners LLC purchased a new position in Paragon 28 during the 3rd quarter valued at about $91,000. Creative Planning acquired a new position in shares of Paragon 28 in the 3rd quarter valued at about $91,000. Finally, Palumbo Wealth Management LLC purchased a new stake in shares of Paragon 28 in the fourth quarter worth approximately $171,000. 63.57% of the stock is currently owned by institutional investors and hedge funds.

Paragon 28 Trading Down 0.0 %

Shares of FNA stock opened at $13.06 on Tuesday. The business’s 50 day moving average is $11.24 and its two-hundred day moving average is $8.78. The company has a quick ratio of 1.60, a current ratio of 3.50 and a debt-to-equity ratio of 0.79. Paragon 28, Inc. has a 12 month low of $4.65 and a 12 month high of $14.78. The company has a market cap of $1.09 billion, a PE ratio of -17.64 and a beta of 1.54.

Insider Activity at Paragon 28

In other news, major shareholder Mvm Partners, Llc sold 20,136 shares of Paragon 28 stock in a transaction dated Thursday, January 23rd. The stock was sold at an average price of $11.63, for a total value of $234,181.68. Following the transaction, the insider now directly owns 10,366,009 shares in the company, valued at approximately $120,556,684.67. The trade was a 0.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In the last three months, insiders have sold 300,192 shares of company stock worth $3,135,086. 15.32% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. Stephens reiterated an “equal weight” rating and issued a $13.00 price objective (down previously from $14.00) on shares of Paragon 28 in a research note on Thursday, January 30th. Canaccord Genuity Group reaffirmed a “hold” rating on shares of Paragon 28 in a research note on Wednesday, January 29th. William Blair cut Paragon 28 from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. Finally, Needham & Company LLC reaffirmed a “hold” rating and issued a $13.00 target price on shares of Paragon 28 in a research report on Wednesday, January 29th. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, Paragon 28 has a consensus rating of “Hold” and a consensus target price of $14.60.

Paragon 28 Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.